jun 6, 2018: 4:45 p.m. - 5:45 p.m.
Room 259A, Level 2
After the US, Europe is the world’s top hub for biotech innovation. This session will showcase the value of investing in European biotech, and feature high-level speakers including EU policymakers, national associations and companies. They will show how biotech investors and SMEs can do business in Europe and what opportunities the region offers to biotech innovators.
John Brennan, Secretary General, EuropaBio
1. Pilar Aguar Fernandez: Head of Unit, Innovative tools, technologies and concepts in health research, DG Research and Innovation, European Commission
2. Leonor Enes: Scientific Officer, SME Office, Corporate Stakeholders Department, European Medicines Agency
3. Peter Heinrich: Chairman of the Board of Directors at Injex Pharma AG and Managing Director and Partner at Sinfonie Life Science Management GmbH (Germany)
4. Andrew Obenshain: Head of Europe, Bluebird Bio (US)